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Abstract
Background: The Veterans Health Administration (VHA) oversees the largest integrated healthcare system in the
United States. The feasibility of a large-scale, nationwide, group-randomized implementation trial of VHA outpatient
practices has not been reported. We describe the recruitment and enrollment of such a trial testing a clinician-
directed, Internet-delivered intervention for improving the care of postmyocardial infarction patients with multiple
comorbidities.
Methods: With a recruitment goal of 200 eligible community-based outpatient clinics, parent VHA facilities
(medical centers) were recruited because they oversee their affiliated clinics and the research conducted there.
Eligible facilities had at least four VHA-owned and -operated primary care clinics, an affiliated Institutional Review
Board (IRB), and no ongoing, potentially overlapping, quality-improvement study. Between December 2003 and
December 2005, in two consecutive phases, we used initial and then intensified recruitment strategies.
Results: Overall, 48 of 66 (73%) eligible facilities were recruited. Of the 219 clinics and 957 clinicians associated
with the 48 facilities, 168 (78%) clinics and 401 (42%) clinicians participated. The median time from initial facility
contact to clinic enrollment was 222 days, which decreased by over one-third from the first to the second
recruitment phase (medians: 323 and 195 days, respectively; p < .001), when more structured recruitment with
physician recruiters was implemented and a dedicated IRB manager was added to the coordinating center staff.
Conclusions: Large group-randomized trials benefit from having dedicated physician investigators and IRB
personnel involved in recruitment. A large-scale, nationally representative, group-randomized trial of community-
based clinics is feasible within the VHA or a similar national healthcare system.
Introduction
Implementation research is the scientific study of meth-
ods to promote the rapid uptake of research findings
and, hence, improve the health of individuals and popu-
lations [1]. Group-randomized trials (GRTs) are an
increasingly important tool for implementation research.
Typically, individuals (e.g., clinicians) are clustered
within subunits (e.g., clinics) that may be further clus-
tered within higher-level units (e.g., facilities or health
systems). Accordingly, the unit of randomization and
the intervention target may be different (e.g., clinics and
clinicians, respectively). Unlike the traditional rando-
mized clinical trial (RCT), which focuses on efficacy,
implementation research focuses on effectiveness [2,3].
The goal is to understand how efficacious interventions
delivered in relatively homogenous populations can be
deployed within the community to benefit the popula-
tion at large. Thus, external validity (generalizability) of
GRTs depends on the extent that participants at differ-
ent levels of clustering represent the population of
interest.
Recruitment is important for traditional RCTs, pri-
marily to achieve the needed power to detect significant
differences in outcomes; for GRTs, recruitment is
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important to ensure power and generalizablity. The
Myocardial Infarction Plus Comorbidities (MI-Plus)
study was a nationwide GRT of Veterans Health Admin-
istration (VHA) primary care clinicians who cared for
ambulatory post-myocardial infarction (MI) patients,
many of whom had multiple comorbidities. The 27-
month clinician-directed, Internet-delivered intervention
consisted of quarterly case-based interactive educational
modules, one to three reviews per month of recently
published studies of high clinical impact and relevance
to the quality indicators, summaries and links to guide-
lines applicable to the care of post-MI patients, and
downloadable practice tools and patient educational
materials [4]. The website was developed using service-
oriented architecture and design principles refined in
prior studies [5,6]. Iterative usability sessions were used
to refine the content. Clinicians in control clinics were
provided a link to an existing VHA Office of Quality
and Performance website that contained links to a wide
range of clinical guidelines for various medical condi-
tions (http://www.healthquality.va.gov/).
Similar to other multicenter implementation studies,
the clinic was the unit of randomization [7]. Perfor-
mance improvement was calculated as the change (pre-
intervention period vs. postintervention period) in the
proportion of patients receiving each clinical indicator
within the clinic [8]. Individual clinicians were
embedded within community-based outpatient clinics
(clinics), which were embedded organizationally, though
not necessarily colocated, within VHA parent facilities
(medical centers). This design necessitated several
sequential and, at times, simultaneous recruitment
efforts targeting individual clinicians, clinics, and facil-
ities. This report describes those recruitment activities
as well as the recruitment times and participation rates
at the facility, clinic, and clinician level.
Methods
The VHA is the largest integrated healthcare system in
the United States, with 153 medical centers and over
900 ambulatory care and community-based outpatient
clinics providing care to an estimated 5.5 million indivi-
duals in 2008 [9]. Each facility typically consists of an
acute care component, on-site outpatient clinics physi-
cally located at the facility, and off-site outpatient clinics
distributed across the region served by the facility. Many
facilities are also affiliated with an academic medical
center and support research activities. Research within
the facility must be formally approved by the facility’s
Institutional Review Board (IRB) and its Research and
Development (R&D) committee. Any research con-
ducted at a clinic is governed by the policies of its par-
ent facility.
The study was funded through the VHA Health Ser-
vices Research and Development (HSR&D) office [IHD
04-387] and by a parallel National Institutes of Health
study [R01 HL70786-02][10,11]. We conducted forma-
tive work with a panel of expert physicians using nom-
inal group techniques to choose from among 36
potential quality indicators for complex ambulatory
post-MI patients that would be both most feasible and
most valid [8]. We also conducted focus groups and
case-vignette surveys of clinicians, including VHA clini-
cians, to develop the intervention. The Birmingham VA
Medical Center, Birmingham, AL, served as the study’s
coordinating center. After approval from its IRB and
R&D committees, the Birmingham facility and its six
affiliated outpatient clinics were the first study enrollees
in November 2003.
A priori, we planned a sample size of 200 clinics to
provide > 80% statistical power to detect a 5% difference
in improvement between intervention and control
clinics for all of the primary clinical indicators over a
range of assumptions. Our initial recruitment plan
allotted six months to recruit the 200 clinics using a
strategic approach of recruiting parent facilities using
high-yield targets (i.e., personal contacts) and leveraging
regional leadership support for our study. As only one-
third of the requisite clinics were recruited after eight
months, we re-evaluated the initial recruitment proce-
dures (phase 1) and revised them to improve recruit-
ment in phase 2.
Phase 1 facility recruitment protocol
In the first phase of recruitment (April 2004-November
2004), potential facilities for recruitment were identi-
fied using the 2003 VA Station Tracking (VAST) data-
base. To be eligible, facilities had to have an affiliated
IRB; four or more eligible clinics; and no ongoing,
potentially overlapping, quality-improvement project.
The four-clinic requirement was relaxed towards the
end of recruitment. Clinics were eligible if they were
noncontract (owned and operated by VHA), delivered
primary care, used the VHA’s electronic health record
(EHR) system, and provided Internet access to all clini-
cians. For eligible facilities, we sought a physician will-
ing to serve as a local principal investigator (PI). To
identify funded investigators and other potential con-
tacts within each facility who could serve as a local PI,
the VHA R&D and HSR&D websites were reviewed.
The subsequent list was reviewed by our study investi-
gators to identify high-yield targets (i.e., personal con-
tacts) to initiate facility recruitment. The project
coordinator (a registered nurse) called and emailed
these high-yield targets on behalf of the study
investigators.
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Phase 2 facility recruitment protocol
In the second phase of facility recruitment (December
2004-July 2005), “cold” contacts were recruited via
emails and telephone by targeting facilities with the
largest number of associated clinics. To increase recruit-
ment and its efficiency, we developed and implemented
a standardized recruitment protocol (Figure 1). During
this second phase, we added two physician investigators
Figure 1 Facility recruitment scheme (phase 2): the VA MI-Plus study.
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to assume primary responsibility for recruitment of local
PIs and leverage physician-to-physician communications
[12]. To facilitate the IRB approval process at participat-
ing facilities, a research assistant was also hired to speci-
fically oversee all IRB protocols and to prepare a
standard IRB packet for each facility. In phase 1,
research staff assisted each facility with IRB preparation
but did not prepare a standard IRB packet. The 14 facil-
ities for which a local PI could not be found or for
which IRB approval was never obtained were classified
as “declined” facilities (Figure 2).
The physician investigators followed the recruitment
protocol shown in Figure 1. Contact information
(name, position, telephone number, and email) for
potential physician PIs was obtained from the VAST
database and facility websites. These initial emails con-
tained recruitment materials (the study abstract, a
press release, and a recruitment letter), outlined the
need for a local PI, and described the general
expectations of this position. During the telephone
call, questions were answered, interest was ascertained,
and if the individual declined to participate, they were
asked to refer others who might be interested. This
process was continued until a local PI was identified
or all leads were exhausted, including contacting the
chief of medicine, IRB chair, and chief of staff. To
cover costs of participation, the facility received a site
distribution of $2,500.
Facilities were recruited until we achieved our goal of
200 eligible clinics. While facility recruitment continued
in a rolling fashion, we simultaneously recruited clinics
and clinicians of enrolled facilities to participate in the
intervention study. Clinicians at each facility’s associated
clinics were not recruited or provided study materials
until a local PI was identified, all IRB requirements were
met, and a list of all eligible clinicians and their email
addresses were obtained. The date these materials were
approved and posted was the facility’s launch date.
Figure 2 Facility participation: the VA MI-Plus study.
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Clinic and clinician recruitment protocol
A clinic was enrolled and randomized when the first eligi-
ble clinician (a physician, physician assistant, or nurse
practitioner) at that clinic logged on to the study website.
All clinicians at a clinic were randomized to the same arm,
but only clinicians who logged on were enrolled. Clinicians
were recruited continuously throughout the two-year
intervention period. Immediately following the facility
launch, clinicians were sent an email, a postal letter, and
study flier that described the study and how to log on to
the study webpage. Subsequent weekly email and fax
reminders were sent to clinicians who had not yet logged
on. Approximately four to six weeks after the facility
launch date, one of the study physicians sent a more per-
sonalized email to each clinician at clinics not yet enrolled
(this involved seven clinics over the course of the study). If
unsuccessful, telephone contact was attempted with each
clinician at clinics not yet enrolled. Telephone attempts
were discontinued if a clinician was reached or three
attempts were made. The date and type of contact attempt
was tracked in an Excel (Microsoft Corporation, Red-
mond, WA, USA) spreadsheet; however, more recent con-
tact attempts were overwritten on earlier attempts. The
primary goal of these attempts was to increase clinic
enrollment and not clinician enrollment (i.e., if any clini-
cian at a given clinic logged on, the clinic was considered
to be enrolled). Proactive emails were sent notifying all
clinicians (enrolled or nonenrolled) of new updates and
materials. Such reminders have been demonstrated to
increase participation in Internet-delivered clinician inter-
ventions [13]. Lastly, a monthly recruitment report was
emailed to the local PI at the associated parent facility.
The report contained the name of each clinician and his/
her enrollment status. Local PIs were encouraged to infor-
mally facilitate recruitment where feasible by encouraging
their peers to log on. All enrolled intervention and control
clinicians could obtain continuing education credits for
reviewing eligible educational materials on the website. No
other incentives were provided owing to VHA policy.
Statistical analysis
Differences in facility participation rates were assessed
according to the presence of a formally funded existing
VHA HSR&D program at the time of recruitment
(defined as a Center of Excellence, Research Enhance-
ment Award Program, or a Targeted Research Enhance-
ment Program), rural-urban locale,[14] geographic
region of the United States, and facility size in terms of
number of affiliated clinics. Differences in clinic partici-
pation rates among participating facilities were similarly
assessed, with clinic size classified according to the
number of affiliated clinicians. The analyses were
repeated among participating facilities to assess differ-
ences by recruitment phase.
We defined four time intervals to represent the differ-
ent aspects of the total recruitment time for a clinic: (1)
initial facility contact to recruitment of a local PI, (2)
recruitment of a local PI to approval by both the R&D
committee and the IRB, (3) IRB or R&D approval (which-
ever the facility required last) to launch, and 4) launch to
first clinic enrollment. Interval 2 represents an estimate
of facility approval time. Because all time intervals were
skewed, the median was used as a measure of central ten-
dency. Kruskal-Wallis tests were used to assess differ-
ences of time variables across categorical variables, and
Spearman rank correlations were used to measure asso-
ciations of selected characteristics, specifically, measures
of facility and clinic size, with time intervals.
Results
Facility participation
Of 118 facilities identified as potentially eligible (Figure
2), 66 were confirmed eligible. Of the 66, 12 had a for-
mally established VA HSR&D program and 59 were in
an urban area (Table 1). The largest proportion (n = 23,
35%) was in the midwest and the lowest in the west (n
= 12, 18%). The median number of affiliated clinics was
five (interquartile range of four to six). Forty-eight facil-
ities (73%) located across the continental United States
(Figure 3) participated. Facility participation rates were
higher among facilities with a formally established VA
HSR&D program, those located in an urban area, those
not in the west, and those that were smaller (Table 1).
For the 18 facilities that did not participate, a willing PI
could not be identified in 14 (Figure 2), with two facilities
citing serious staffing problem/staffing turnover as reasons.
Willing PIs were found at another 4 of the 18 facilities but
their research offices declined for two of them, and another
two never completed the IRB approval process.
Clinic participation
There were 219 clinics affiliated with the 48 participat-
ing facilities, of which 168 (77%) participated (Table 2).
As with facilities, most clinics were located in urban
areas, with relatively few in the west. The median clinic
size (number of clinicians) was 3 (range 1 to 15). Larger
clinics and clinics located in urban areas were more
likely to participate than their counterparts; clinic parti-
cipation did not differ by US region.
Clinician participation
There were 957 clinicians affiliated with the 219 clinics,
of whom 401 (42%) participated (Table 2). In contrast
to clinic participation rates, clinician participation rates
did not differ by rural-urban locale or clinic size. As
with clinics, clinician participation rates did not differ
by geographic region within the continental United
States.
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Facility recruitment time
Excluding the coordinating center, the facilities were
recruited over a 15-month period. Between April 2004
and November 2004, 16 facilities (25% of 65 eligible)
were recruited, and between December 2004 and July
2005, 31 facilities were recruited (63% of 49 remaining
eligible) (Figure 4). The median time from initial facility
contact to clinic enrollment was 222 days. This interval
decreased by over a third, from a median of 323 to 195
days (p < .001), from the first to second recruitment
Table 1 Distribution of eligible facilities according to participation: the VA MI-Plus study
Participated
Characteristics ALL (N = 66) YES (N = 48) NO (N = 18) p
N % N % N %
Had a VHA health services research program 12 18.2 12 25.0 0 0.0 .03
Located in an urban area 59 89.4 45 95.7 14 77.8 .045
Geographic region .03
New England/Mid-Atlantic 16 24.2 14 29.2 2 11.1
Midwest 23 34.8 16 33.3 7 38.9
South 15 22.7 13 27.1 2 11.1
West 12 18.2 5 10.4 7 38.9
Number of affiliated outpatient clinics .07*
2-3 16 24.2 14 29.2 2 11.1
4-5 30 45.4 22 45.8 8 44.4
6-15 20 30.3 12 25.0 8 44.4
Median (interquartile range) 4.5 (4-6) 4 (3-5.5) 5 (4-7) .02**
*p for trend test; **p for Wilcoxon rank sum test.
VHA = Veterans Health Administration.
Figure 3 Geographic locations of participating facilities: the VA MI-Plus study.
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phase (Figure 5). This was largely due to a decrease in
facility approval time (255 to 94 days; p < .001), which
remained the largest component of recruitment time. In
all but three facilities, approval by the R&D committee
was required before submission for IRB approval. This
initial approval constituted 80% (93 of 116 days) of over-
all median facility approval time, a percent similar for
both phases of the study. Initial contact time (i.e., time
to identification of local PI) did not differ by facility size
overall (r = .01) or in either phase. Facility approval
time was associated with facility size in the first phase (r
= .68) but not the second phase (r = -.01). As expected,
clinic size was inversely (r = -.51) associated with time
from facility launch date to clinic enrollment (participa-
tion); namely, clinics with more clinicians had a clinician
log on sooner than did clinics with fewer clinicians, and
this association was present in both recruitment phases
of the study.
Clinic/clinician recruitment time
Over half (n = 90; 53%) of the clinics enrolled within
one week of facility launch and most (n = 146; 87%)
enrolled within four weeks. Six weeks after facility
launch, only 7% of clinics had not enrolled. This pattern
was the same for both recruitment phases. The longest
time period to enroll a clinic was 10 weeks (n = 3
clinics). Regarding time to last new clinician logging on
within a clinic, 25% of clinics had the last new clinician
participate by four weeks, 50% by 7.5 weeks, and 75% by
28 weeks. One clinic had a clinician who first logged on
80 weeks after initial invitation. Although we did not
formally gather information on clinician refusal, which
was passive, qualitatively, most clinicians who did not
enroll and were reached by telephone cited lack of time
and interest as reason for not participating.
Discussion
The possibility of obtaining a large, nationally represen-
tative sample of primary care clinicians (physicians, phy-
sician’s assistants, and nurse practitioners) makes the
VHA health system an enticing setting to conduct
implementation and outcomes research. With careful
planning, a systematic yet flexible approach, and a mul-
tidisciplinary staff, it is possible to recruit a nationwide
sample of primary care clinicians employed in the
VHA’s community-based outpatient clinics. Over
approximately two years, we were able to recruit 401
clinicians representing 168 clinics and 48 facilities in 26
states and Puerto Rico and the Virgin Islands. These
groups accounted for 73% of all eligible facilities, over
75% of their associated clinics, and 42% of their
clinicians.
Most GRTs do not report a response rate as they have a
target number of “groups” or practices to recruit for the
purposes of statistical power [15] and do not identify, or at
least report, a sampling denominator. Our facility and
clinic response rates were much higher than the 27% of
nursing homes in a GRT study of osteoporosis fracture
prevention [16] or the 33% of practices in a managed-care
organization’s study to increase chlamydia screening [5].
Our response rate is similar to non-GRT studies where
the purpose was to obtain a population-based nationwide
sample. For example, the National Institutes of Health-
funded Coronary Artery Risk Development in Young
Adults (CARDIA) study has been following an initial
cohort of 5,115 community-dwelling healthy young adults
first recruited in 1985 for nearly 25 years. The initial 1985
recruitment for CARDIA resulted in a 55% response rate
[17]. CARDIA has significantly contributed to our scienti-
fic knoweldge, having resulted in over 400 peer-reviewed
publications. More recently, the National Institues of
Health-funded Cancer Outcomes Research Consortium
(CanCORS) was established in 2001 to obtain a represen-
tative, population-based sample to study the processes and
outcomes of patients with newly diagnosed lung or color-
ectal cancer [18]. The approximately 10,000 cancer
patients recruited with a population-based approach
represent about 50% of the underlying target population.
As the recruitment methodologies of GRTs become more
refined, their findings will be highly generalizable.
Table 2 Distribution of community-based outpatient
clinics and associated clinicians among the 48
participating facilities: the VA MI-Plus study
Clinics Clinicians
Total Participating Total Participating
N N % N N %
ALL 219 168 76.7% 957 401 41.9%
Located in an urban areaa
Yes 171 139 81.3% 828 350 42.3%
No 42 26 61.9% 100 44 44.0%
p = .007 p = .7
Geographic region
New England/Mid-
Atlantic
62 48 77.4% 199 98 49.2%
Midwest 70 55 78.6% 273 117 42.9%
South 63 48 76.2% 373 145 38.9%
West 18 14 77.8% 83 34 41.0%
Puerto Rico & Virgin
Islands
6 3 50.0% 29 7 24.1%
p = .6 p = .046
Number of clinicians
1 38 18 47.4% 39 17 43.6%
2-3 93 71 76.3% 227 107 47.1%
≥ 4 88 79 89.8% 691 277 40.1%
p < .001 p = .2
aDoes not include the six clinics and 29 clinicians from Puerto Rico & the
Virgin Islands.
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Recruiting for GRTs and for RCTs can be viewed
under similar theoretical perspectives, including Choo’s
general model of information use identifying major ele-
ments that influence information-seeking behavior [19]
and the work of Christensen and Armstrong involving
diffusion of innovation [20], which includes “disruptive”
effects. In the VA MI-Plus study, recruitment involved
two groups of clinicians: (1) physicians to identify a
local PI and (2) clinicians to log on and participate in
the intervention. These clinician groups may have differ-
ent elements that influence their participation. Local PIs
had to complete necessary IRB training and submit
applications through R&D and IRB committees for
study approval at their facility. Even with the parent site
(Birmingham) preparing necessary packages in the sec-
ond phase, obtaining these approvals could be quite
time consuming. There was no direct compensation to
these individuals. Reasons to participate, as cited by
another GRT [21], may include the desire to improve
their clinical practice or an interest in contributing to
medical knowledge in general, but these benefits must
exceed any perceived disruptive effects. In comparison,
at the clinic level, a clinician simply had to log on to
enroll and thus be classified as participating.
In comparing phase 1 and phase 2 recruiting, we
found, as have others [21,22], that physician-to-physi-
cian recruiting gave a much greater yield and that prior
personal contacts did not have a substantial effect. We
also learned that recruitment strategies needed to
change over time in order to achieve recruitment tar-
gets. Similarly, Ellis et al. [21] used 10 different nonran-
domized strategies over 11 months to recruit sufficient
practices in the GLAD HEART study, a total of 61 prac-
tices, all within one US state. In a review of recruitment
rates and strategies across studies conducted in one
medical center, Johnston et al. [23] found considerable
variation in recruitment rates despite similar strategies
and staffing. Number of recruited practices ranged from
30 to 137; most required over nine months to recruit
and most had not planned for the time needed. They
found personal connections helpful and have suggested
that these personal connections can be developed during
the recruiting process. We also found that buy-in from
participants (the use of local PIs to champion the study)
Figure 4 Cumulative enrollment by month: the VA MI-Plus study.
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and a flexible recruitment strategy enhanced recruit-
ment, findings consistent with those of Johnston et al.
[23]
Minimization of possible disruptive effects for the
clinician may have facilitated recruitment in our study.
First, VHA’s use of EHRs made it possible to extract
patient records without interfering with office flow.
Also, randomization and analysis was at the clinic level,
thus low-performing individual clinicians were not at
risk of being identified. Similarly, the use of EHRs and
clinics as the randomization unit enabled the recruit-
ment of 20 practices in 14 states for a multimethod
GRT [24]. The Ornstein study relied on academic detail-
ing and site visits, components that may be disruptive
from the theoretical perspective and expensive or
impractical for a nationwide study. Interestingly, the
parallel MI-Plus study involving primary care clinicians
in Alabama and Mississippi [25,10,8] had a much lower
participation rate (13%) for clinicians [25], perhaps
because these clinicians lacked EHRs and viewed manual
chart abstraction as disruptive to their practices.
Between the first and second phases of our recruit-
ment, the amount of time required to obtain facility
approval of the study protocol decreased from a median
of 255 days to 94 days. This 63% reduction was primar-
ily attributed to the addition of an experienced IRB staff
member at the Study Coordinating Center that allowed
for the implementation of a more systematic and struc-
tured approach to IRB management. The complexity
and sheer volume of work needed to coordinate IRB
approval for 48 participating facilities cannot be over-
stated. The majority of facilities required R&D approval
prior to IRB submission, and obtaining R&D approval
constituted the bulk of the facility approval time, with
IRB approval requiring only an additional two to four
weeks. This may be misleading in that many R&D com-
mittees wanted “the essence of the IRB packet” to
review, thus, an IRB specialist is invaluable in facilitating
R&D approval as well.
Establishment of the recently implemented central IRB
in the VHA (an IRB approved by a central office to
cover all participating facilities in a multisite study)
should enhance the efficiency, cost, and attractiveness of
conducting nationwide GRTs within the VHA. Use of
single-study IRB cooperative agreements in the (beta)-
Carotene and Retinol Efficacy Trial (CARET) in a uni-
versity setting reduced the average time to complete IRB
approval from over six months to one month for each of
Figure 5 Median number of days for component intervals from initial facility contact to first clinic enrollment: the VA MI-Plus study.
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many substudies [26]. Even with a central IRB, we
anticipate, as have others [27-29], that a dedicated
research assistant or IRB specialist is advised in the
planning of any large GRT within or external to the
VHA. In 2005, with an established protocol and experi-
enced staff, it took approximately six months from
initial contact at a facility to enroll an associated clinic;
half of this time (three months) was for facility approval,
which perhaps can be reduced to one month with the
central IRB recently implemented by the VHA. One
challenge that will remain, even with a central IRB, is
getting PIs to do requisite training in research practices
(e.g., good clinical practices, privacy, and security train-
ing) needed for IRB approval. This required substantial
effort from our study staff, primarily that of the IRB spe-
cialist. In an era of ever-increasing regulatory oversight,
we believe that this will persist as a substantial task that
should be planned for when designing studies and bud-
geting personnel. A database of and for VHA research-
ers to register and complete the approval and training
necessary to do VHA research should facilitate the
recruitment process.
Our conclusions regarding the importance of a func-
tional, truly interdependent relationship between the
study PI and the clinical research coordinator echo
those of other teams [30]. The success of our study
would not have been possible without a close collabora-
tion between these two members of the research team.
Evaluating the value-added contribution of such a posi-
tion should be an important future consideration.
Our experience suggests that using a recruitment
approach that seems counterintuitive might be war-
ranted. Our initial efforts to recruit local PIs focused on
high-yield targets (i.e., personal contacts), largely due to
initial anxiety on the part of the recruitment team of
cold calling. While recruiting based on familiarity might
have made us feel better, the cold peer-to-peer calling
successfully recruited many local PIs and proved less
difficult and more efficient than anticipated. We might
have saved time and improved study efficiency by
expending more energy on cold calling local PIs early
and getting the recruitment process started and saving
the “easy” recruits for later. Anecdotally, cold calling
individual clinicians to log on was not nearly as success-
ful a recruitment tool as cold calling for local PIs. This
observation may be a result of being able to offer the
facility of local PIs a site distribution of funds ($2,500)
to cover costs of participating, while we could not offer
clinicians any similar distribution of funds for participa-
tion in the study owing to VHA policy.
Conclusions
We found that having dedicated research team mem-
bers, physician investigators, and an IRB specialist
actively involved in the recruitment process and using a
standardized recruitment protocol greatly increased the
ability and efficiency of facility recruitment. These spe-
cialized personnel, however, appeared to have very little
effect on recruiting clinics and clinicians. We believe
that our study demonstrates the ability to do implemen-
tation research with a level of generalizability compar-
able to that of major epidemiologic studies. As group-
randomized implementation trials become more com-
mon, large healthcare systems, such as the VHA, will
provide us with the opportunity to refine our methods
and become key “laboratories” for the development of
implementation science.
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